Baxter Recalls Heparin Sodium Due to Subpotent Drug Risk
Baxter Healthcare recalls specific lots of Heparin Sodium and 0.9% Sodium Chloride Injection due to subpotent drug issues. Check lot numbers N002998, N003004, and N003038.
Stop using this now
Subpotent Drug; out of specification results for heparin raw material
Contact the company
What happened, in plain English
Baxter Healthcare Corp. is recalling specific lots of Heparin Sodium and 0.9% Sodium Chloride Injection because the heparin raw material resulted in subpotent drug levels that are out of specification. This means the medication may not provide the expected therapeutic effect for patients who rely on it to prevent or treat blood clots. The recall affects 145,350 containers distributed nationwide. Read more at govinfonow.com/recall/44209-baxter-healthcare-corp-recalls-heparin-sodium-and-0-9-sodium.
Source Summary by GovInfoNow · govinfonow.com/recall/44209-baxter-healthcare-corp-recalls-heparin-sodium-and-0-9-sodium · Updated October 12, 2026 · FDA enforcement record: FDA #D-1131-2015
Cite this page
“Baxter Recalls Heparin Sodium Due to Subpotent Drug Risk.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/44209-baxter-healthcare-corp-recalls-heparin-sodium-and-0-9-sodium. Based on FDA recall #D-1131-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1131-2015%22&limit=1).
Why it’s dangerous
The hazard is that the drug is subpotent due to out-of-specification results for the heparin raw material. If the concentration of heparin is lower than labeled, it may fail to adequately prevent or treat blood clots, leading to potential serious medical complications.
Who’s affected
Patients prescribed Heparin Sodium and 0.9% Sodium Chloride Injection by Baxter Healthcare Corp. are affected. Individuals relying on this specific medication for anticoagulation therapy are at risk of receiving a subpotent dose.
How to tell if you have this one
Look for Heparin Sodium and 0.9% Sodium Chloride Injection in a VIAFLEX Plus Container, Rx Only. Check the NDC 0338-0431-03 and Product Code 280953. Affected lots are N002998 (exp 12/31/15), N003004 (exp 12/31/15), and N003038 (exp 01/31/2016).
- Brand
Baxter Healthcare Corp.- Category
Drug
What to do — step by step
Check Lot Numbers
Verify if your medication matches the recalled lots N002998, N003004, or N003038 with expiration dates of 12/31/15 or 01/31/2016.
Contact Healthcare Provider
If you have the recalled product, contact your healthcare provider immediately for instructions on replacement or alternative treatment.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 21 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
How many containers are being recalled?
A total of 145,350 containers are included in this recall.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1131-2015 (June 3, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1131-2015 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.